Literature DB >> 15989185

Evaluation of ameroid ring constrictors for treatment for single extrahepatic portosystemic shunts in dogs: 168 cases (1995-2001).

Margo L Mehl1, Andrew E Kyles, Elizabeth M Hardie, Philip H Kass, Christopher A Adin, Alison K Flynn, Hilde E De Cock, Clare R Gregory.   

Abstract

OBJECTIVES: To evaluate use of an ameroid ring constrictor (ARC) for treatment for single extrahepatic portosystemic shunts (PSSs) and identify factors associated with postoperative death, continued portosystemic shunting, and long-term outcome in dogs.
DESIGN: Retrospective study. ANIMALS: 168 dogs with a single extrahepatic PSS. PROCEDURE: Medical records of dogs that had a single extrahepatic PSS and were treated with an ARC were reviewed. Signalment, history, clinical signs, results of preoperative blood analyses and portal pressure measurements, PSS location, ARC size, postoperative complications, and postoperative scintigraphy results were recorded. Owners were interviewed 6 months to 6 years after surgery. Results-Postoperative complications developed in 10% of dogs. Postoperative mortality rate was 7.1%. Predictive factors for postoperative death included high preoperative WBC count and postoperative complications. Twenty-one percent of dogs in which portal scintigraphy was performed 6 to 10 weeks after surgery had continued shunting. Predictive factors for persistent shunting included low preoperative plasma albumin concentration, high portal pressure after complete occlusion, and high portal pressure difference (postocclusion minus baseline). Clinical outcome in 108 dogs was classified as excellent (80%), good (14%), or poor (6%). Predictive factors for excellent long-term clinical outcome included high preoperative plasma albumin concentration, low preoperative leukocytosis, low portal pressure after complete occlusion, absence of postoperative seizures, and absence of continued shunting. CONCLUSIONS AND CLINICAL RELEVANCE: Use of an ARC for treatment for a single extrahepatic PSS resulted in low morbidity and mortality rates. Certain preoperative factors were associated with increased risk of postoperative death, continued portosystemic shunting, and long-term outcome.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15989185     DOI: 10.2460/javma.2005.226.2020

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  11 in total

1.  Evaluation of surgical outcome, complications, and mortality in dogs undergoing preoperative computed tomography angiography for diagnosis of an extrahepatic portosystemic shunt: 124 cases (2005-2014).

Authors:  Benjamin W Brunson; J Brad Case; Gary W Ellison; W Alexander Fox-Alvarez; Stanley E Kim; Matthew Winter; Fernando L Garcia-Pereira; Lisa L Farina
Journal:  Can Vet J       Date:  2016-01       Impact factor: 1.008

2.  Assessment of in vivo fetal growth and placental vascular function in a novel intrauterine growth restriction model of progressive uterine artery occlusion in guinea pigs.

Authors:  Emilio A Herrera; René Alegría; Marcelo Farias; Farah Díaz-López; Cherie Hernández; Ricardo Uauy; Timothy R H Regnault; Paola Casanello; Bernardo J Krause
Journal:  J Physiol       Date:  2016-02-02       Impact factor: 5.182

3.  Evaluation of hepatic steatosis in dogs with congenital portosystemic shunts using Oil Red O staining.

Authors:  G B Hunt; J A Luff; L Daniel; R Van den Bergh
Journal:  Vet Pathol       Date:  2013-03-25       Impact factor: 2.221

4.  Successful ligation of the left and right gastric vein in a dog with congenital portosystemic shunts type Aii.

Authors:  Yusuke Ozai; Akiko Uemura; Ryou Tanaka; Seijirow Goya; Kazumi Shimada
Journal:  Can Vet J       Date:  2022-02       Impact factor: 1.008

5.  Distribution of extrahepatic congenital portosystemic shunt morphology in predisposed dog breeds.

Authors:  Lindsay Van den Bossche; Frank G van Steenbeek; Robert P Favier; Anne Kummeling; Peter A J Leegwater; Jan Rothuizen
Journal:  BMC Vet Res       Date:  2012-07-11       Impact factor: 2.741

6.  Changes in chemical and ultrastructural composition of ameroid constrictors following in vitro expansion.

Authors:  Thomas S Anderson; Graham A Rance; Long Jiang; Matthew J Piggott; Elinor J Field; Guillaume P Chanoit
Journal:  PLoS One       Date:  2018-11-15       Impact factor: 3.240

7.  Astrocyte lesions in cerebral cortex and cerebellum of dogs with congenital ortosystemic shunting.

Authors:  Alun Williams; Adam Gow; Scott Kilpatrick; Mickey Tivers; Vicky Lipscomb; Ken Smith; Michael Oliver Day; Nick Jeffery; Richard John Mellanby
Journal:  J Vet Sci       Date:  2020-05       Impact factor: 1.672

8.  Quantitative evaluation of contrast-enhanced ultrasonography in the diagnosis of chronic ischemic renal disease in a dog model.

Authors:  Yi Dong; Wenping Wang; Jiaying Cao; Peili Fan; Xiyuan Lin
Journal:  PLoS One       Date:  2013-08-01       Impact factor: 3.240

9.  Genome-wide based model predicting recovery from portosystemic shunting after liver shunt attenuation in dogs.

Authors:  Lindsay Van den Bossche; Frank G van Steenbeek; Maarten F Weber; Bart Spee; Louis C Penning; Freek J van Sluijs; Flin Zomerdijk; Marian J A Groot Koerkamp; Jan Rothuizen; Iwan A Burgener; Anne Kummeling
Journal:  J Vet Intern Med       Date:  2018-05-17       Impact factor: 3.333

Review 10.  Pediatric seizure disorders in dogs and cats.

Authors:  James A Lavely
Journal:  Vet Clin North Am Small Anim Pract       Date:  2013-12-05       Impact factor: 2.093

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.